Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 1:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 769–792 of 17,841 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Patient Control Clear all

Conditions: Group B Strep Infection
Interventions: Probiotic dietary supplement; Drug
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older · Female only
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Laparoscopic Surgery
Interventions: Carbon dioxide, Bupivacaine, Oxycodone; Other · Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 294 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Endometrial Neoplasms
Interventions: olaparib, durvalumab, durvalumab placebo, olaparib placebo, Carboplatin, Paclitaxel; Drug · Biological
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 150 Years · Female only
Enrollment: 805 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 50
States / cities: Tucson, Arizona • Concord, California • La Jolla, California + 45 more

Conditions: Carpal Tunnel Syndrome
Interventions: Methylprednisolone Injection [Solu-Medrol], wrist splint; Drug · Device
Lead sponsor: Mercy Health Ohio; Other
Eligibility: 18 Years to 75 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Boardman, Ohio

Conditions: Asthma in Children
Interventions: Nurse-delivered education; Other
Lead sponsor: University of Rochester; Other
Eligibility: 7 Years to 14 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Stress Disorders, Post-Traumatic, Depression, Sleep
Interventions: Cognitive Behavioral Therapy, Control; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 64 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Metastatic Renal Cell Carcinoma
Interventions: Sunitinib, GM-CSF, Cyclophosphamide, IMA901; Drug · Biological
Lead sponsor: Immatics Biotechnologies GmbH; Industry
Eligibility: 18 Years and older
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 17
States / cities: Little Rock, Arkansas • Los Angeles, California • Denver, Colorado + 14 more

Conditions: NSTEMI
Interventions: Shared Decision Aid; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 75 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Breastfeeding, Patient Simulation
Interventions: Breastfeeding Skills Workshop; Other
Lead sponsor: LiquidGoldConcept; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Ypsilanti, Michigan

Conditions: Anxiety Disorders, Specific Phobia
Interventions: One-session exposure treatment, Augmented one-session exposure treatment; Behavioral
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 7 Years to 14 Years
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Blacksburg, Virginia

Conditions: Colon Cancer
Interventions: Exercise, Meditation; Behavioral
Lead sponsor: Loyola University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: SIRS, Sepsis
Interventions: Not listed
Lead sponsor: Mochida Pharmaceutical Company, Ltd.; Industry
Eligibility: 21 Years and older
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Tobacco Use
Interventions: Provider Advice, Framed Messaging; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Overactive Bladder
Interventions: StimRouter; Device
Lead sponsor: Bioness Inc; Industry
Eligibility: 22 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 15
States / cities: Tucson, Arizona • Irvine, California • Los Angeles, California + 12 more

Conditions: Lung Cancer
Interventions: educational intervention, medical chart review, questionnaire administration, end-of-life treatment/management, psychosocial assessment and care, quality-of-life assessment; Other · Procedure
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Duarte, California

Conditions: Labor Pain
Interventions: Ultrasound, Palpation; Device · Other
Lead sponsor: Thomas J. Vernon; Other
Eligibility: 18 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Cervical Assessment, Focal Myometrial Contractions
Interventions: Interval bladder emptying; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Bipolar Disorder, Manic
Interventions: Lumateperone, Placebo; Drug
Lead sponsor: Intra-Cellular Therapies, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 351 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 22
States / cities: Bentonville, Arkansas • Little Rock, Arkansas • Anaheim, California + 15 more

Conditions: Obstructive Sleep Apnea Syndrome
Interventions: Xyrem (X), Zolpidem (Z), Modafinil (M), Placebo (P); Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Coronary Artery Disease
Interventions: Methylnaltrexone, Placebo, Morphine, Ticagrelor; Drug · Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Type2 Diabetes, Dyslipidemia
Interventions: K-877, Placebo; Drug
Lead sponsor: Kowa Research Institute, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10,544 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 242
States / cities: Birmingham, Alabama • Gulf Shores, Alabama • Mobile, Alabama + 192 more

Conditions: Prostate Carcinoma
Interventions: Oxybutynin Chloride, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration; Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older · Male only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 103
States / cities: Gilbert, Arizona • Peoria, Arizona • Phoenix, Arizona + 77 more

Conditions: SARS CoV 2 Infection
Interventions: ASC10, Placebo; Drug
Lead sponsor: Ascletis Pharmaceuticals Co., Ltd.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Anniston, Alabama • Hialeah, Florida

Conditions: Germline BRCA1/2 Mutations and, Metastatic Adenocarcinoma of the Pancreas
Interventions: Olaparib, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 20
States / cities: Gilbert, Arizona • Orange, California • Stanford, California + 14 more

Search by objective public record fields.

Group B Streptococcus Response After Probiotic Exposure

Short Title: Standard vs. Lower Pressure Pneumoperitoneum

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A Comparison of Ultrasound-guided Steroid Injection With Wrist Splint in Carpal Tunnel Syndrome

Promoting Partnership and Improving Self-Management for Children With Persistent Asthma

Managing Sleep Symptoms and Modifying Mechanisms of Traumatic Stress

IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI

Evaluation of Health Professional Learners' Competence in Newborn Positioning and Attachment Following a Standardized Patient-led Lactation Skills Workshop

Parent-Augmented Cognitive Behavioral Therapy to Treat Children With Specific Phobias

Strength for Health

Utility of Presepsin in Distinguishing Between Sepsis and SIRS

Pediatric Health Promotion Program

Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial

Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer That Can Be Removed by Surgery

Use of Ultrasound Guidance to Assist With Labor Epidural Placement in Patients With a BMI ≥40

Focal Myometrial Contractions: Impact on Cervical Assessment and Association With Voiding

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients

Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)

Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer

Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients

Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy